Buller HR - Search Results

1

Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.

Brekelmans MP, Ageno W, Beenen LF, Brenner B, Buller HR, Chen CZ, Cohen AT, Grosso MA, Meyer G, Raskob G, Segers A, Vanassche T, Verhamme P, Wells PS, Zhang G, Weitz JI. Brekelmans MP, et al. Among authors: buller hr. Lancet Haematol. 2016 Sep;3(9):e437-45. doi: 10.1016/S2352-3026(16)30080-1. Lancet Haematol. 2016. PMID: 27570090 Clinical Trial.

2

The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders.

Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J. Meinardi JR, et al. Among authors: buller hr. Br J Haematol. 2002 Mar;116(3):625-31. doi: 10.1046/j.0007-1048.2001.03303.x. Br J Haematol. 2002. PMID: 11849222 Free article.

3

Direct thrombin inhibitors in acute coronary syndromes: present and future.

Weitz JI, Buller HR. Weitz JI, et al. Among authors: buller hr. Circulation. 2002 Feb 26;105(8):1004-11. doi: 10.1161/hc0802.104331. Circulation. 2002. PMID: 11864933 Review. No abstract available.

4

Treatment of symptomatic venous thromboembolism: improving outcomes.

Büller HR. Büller HR. Semin Thromb Hemost. 2002 Jun;28 Suppl 2:41-8. doi: 10.1055/s-2002-32315. Semin Thromb Hemost. 2002. PMID: 12073179 Review.

5

Travel and the risk of symptomatic venous thromboembolism.

ten Wolde M, Kraaijenhagen RA, Schiereck J, Hagen PJ, Mathijssen JJ, Mac Gillavry MR, Koopman MM, Büller HR. ten Wolde M, et al. Among authors: buller hr. Thromb Haemost. 2003 Mar;89(3):499-505. Thromb Haemost. 2003. PMID: 12624634

6

The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis.

van Dongen CJ, Vink R, Hutten BA, Büller HR, Prins MH. van Dongen CJ, et al. Among authors: buller hr. Arch Intern Med. 2003 Jun 9;163(11):1285-93. doi: 10.1001/archinte.163.11.1285. Arch Intern Med. 2003. PMID: 12796064

7

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.

Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, Segers AE, Cariou R, Leeuwenkamp O, Lensing AW; Matisse Investigators. Büller HR, et al. Ann Intern Med. 2004 Jun 1;140(11):867-73. doi: 10.7326/0003-4819-140-11-200406010-00007. Ann Intern Med. 2004. PMID: 15172900 Clinical Trial.

8

Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism.

ten Wolde M, Söhne M, Quak E, Mac Gillavry MR, Büller HR. ten Wolde M, et al. Among authors: buller hr. Arch Intern Med. 2004 Aug 9-23;164(15):1685-9. doi: 10.1001/archinte.164.15.1685. Arch Intern Med. 2004. PMID: 15302640 Review.

9

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Büller HR, et al. Chest. 2004 Sep;126(3 Suppl):401S-428S. doi: 10.1378/chest.126.3_suppl.401S. Chest. 2004. PMID: 15383479 Review.

10

Biomarkers in pulmonary embolism.

Söhne M, Ten Wolde M, Büller HR. Söhne M, et al. Among authors: buller hr. Curr Opin Cardiol. 2004 Nov;19(6):558-62. doi: 10.1097/01.hco.0000138991.82347.0e. Curr Opin Cardiol. 2004. PMID: 15502498 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

733 results

Search Page